Chlordiazepoxide for imatinib-induced muscular cramps.
Medeiros
Bruno C
BC
Lipton
Jeffrey H
JH
D000970:Antineoplastic Agents / Q000009:adverse effects; D001549:Benzamides; D002707:Chlordiazepoxide / Q000627:therapeutic use*; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D005260:Female; D018757:GABA Modulators / Q000627:therapeutic use*; D006801:Humans; D000068877:Imatinib Mesylate; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D008875:Middle Aged; D009120:Muscle Cramp / Q000139:chemically induced*; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001549:Benzamides; D018757:GABA Modulators; D016898:Interferon-alpha; D010879:Piperazines; D011743:Pyrimidines; D002707:Chlordiazepoxide; D000068877:Imatinib Mesylate; D003577:Cytochrome P-450 Enzyme System; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human